IL6 and neoplasm: To note, miR-125b acts as tumor-suppressive and inhibits angiogenesis by targeting VEGFA, and induces cell-cycle arrest by directly targeting cyclin D2/E2 & IL-6-stat3 signaling pathway in HCC (28, 29).